BMC Cancer (Feb 2007)

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer

  • Dueñas-Gonzalez Alfonso,
  • Robles Elizabeth,
  • Camargo Maria F,
  • Candelaria Myrna,
  • Vela Teresa,
  • Ramirez Teresa,
  • Villarreal Patricia,
  • Bargallo Enrique,
  • Taja-Chayeb Lucia,
  • Perez-Cardenas Enrique,
  • Trejo-Becerril Catalina,
  • Chavez-Blanco Alma,
  • Revilla-Vazquez Alma,
  • de la Cruz-Hernandez Erik,
  • Gonzalez-Fierro Aurora,
  • Arce Claudia,
  • Perez-Plasencia Carlos

DOI
https://doi.org/10.1186/1471-2407-7-S1-A23
Journal volume & issue
Vol. 7, no. Suppl 1
p. A23

Abstract

Read online

No abstracts available.